Clinical study to evaluate the role of urine pH in Urolithiasis

A Clinical Study To Evaluate The Role Of Urine pH In Urolithiasis Treated With Homoeopathic Medicines - Nil

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/06/069123

Enrollment

Registered

2024-06-18

Start date

Unknown

Completion date

Unknown

Last updated

2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N202- Calculus of kidney with calculus of ureter

Interventions

Intervention1: Homoeopathic medicine: Homoeopathic medicines selected based on symptom similarity will be administrated to the patients in the proper dose, potency, and repetition of medicines accordi

Eligibility

Inclusion criteria

Inclusion criteria: Patients with alteration in urine ph Patients with diagnosed urinary calculi Subjects of both sexes. Age group from 20-60 years.

Exclusion criteria

Exclusion criteria: Pregnant and lactating women Patients with known serious systemic illness. Age less than 20 and more than 60. Patients with Diabetes Ketoacidosis, Urinary tract infection and other kidney related disorders. Patients under medications.

Design outcomes

Primary

Measure	Time frame
Basis of score obtained from USS Chart According to intensity cases were grouped into mild (1-7) , moderate (8-14) and severe (15-22)Timepoint: 6 month	—

Secondary

Measure	Time frame
After completion of study Urolithiasis symptom score and urine ph will be doneTimepoint: 1 year	—

Countries

India

Contacts

Public ContactJ JOSTEL JENSHINI

White Memorial Homoeo Medical College and Hospital

josteljenshini@gmail.com9345862551

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026